|
DOCK9 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.956410E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.27899999982739E-07 |
| Normal-vs-Stage2 |
2.404800E-01 |
| Normal-vs-Stage3 |
9.371400E-01 |
| Normal-vs-Stage4 |
1.277180E-01 |
| Stage1-vs-Stage2 |
5.517900E-02 |
| Stage1-vs-Stage3 |
2.59340000030583E-07 |
| Stage1-vs-Stage4 |
1.98509997328955E-09 |
| Stage2-vs-Stage3 |
2.595600E-01 |
| Stage2-vs-Stage4 |
3.591500E-02 |
| Stage3-vs-Stage4 |
1.086980E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.938100E-03 |
| Normal-vs-AfricanAmerican |
1.055610E-01 |
| Normal-vs-Asian |
4.210400E-01 |
| Caucasian-vs-AfricanAmerican |
7.744000E-01 |
| Caucasian-vs-Asian |
6.449800E-01 |
| AfricanAmerican-vs-Asian |
7.839000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.355700E-03 |
| Normal-vs-Female |
5.477000E-03 |
| Male-vs-Female |
6.655600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.569500E-02 |
| Normal-vs-Age(41-60Yrs) |
4.176700E-04 |
| Normal-vs-Age(61-80Yrs) |
6.379600E-02 |
| Normal-vs-Age(81-100Yrs) |
2.818600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.882600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.533400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.057700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.477900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.458800E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.235830E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.264130E-02 |
| Normal-vs-Grade 2 |
4.05729999597426E-08 |
| Normal-vs-Grade 3 |
7.900600E-01 |
| Normal-vs-Grade 4 |
2.946000E-02 |
| Grade 1-vs-Grade 2 |
2.967700E-02 |
| Grade 1-vs-Grade 3 |
1.360130E-02 |
| Grade 1-vs-Grade 4 |
4.864100E-03 |
| Grade 2-vs-Grade 3 |
9.24400000990033E-09 |
| Grade 2-vs-Grade 4 |
3.36890515484356E-11 |
| Grade 3-vs-Grade 4 |
1.014470E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.54749999481396E-08 |
| Normal-vs-ccB subtype |
4.164600E-01 |
| ccA subtype-vs-ccB subtype |
1.91472999999664E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.860400E-02 |
| Normal-vs-N1 |
5.733900E-02 |
| N0-vs-N1 |
1.167790E-02 |
|
|
